Sofia Lysenko’s parents moved to the United States from the Ukraine when she was 3 years old. Today, at 17, some of the biggest American pharmaceutical companies want to team up with this teenage science prodigy because she has created an artificial macromolecule robot that can deliver drugs directly to the brain cells of patients with Alzheimer’s and Parkinson’s. Iryna Matviichuk met with Sofia to learn more. Anna Rice narrates her report.
Sesran skype chat
recent news
- More money going to African climate startups, but huge funding gap remains
- US Air Force leader takes AI-controlled fighter jet ride in test vs human pilot
- AI scams could become ‘growth industry of all time,’ warns Buffett
- Sanctions, hobbled economy hit Iran’s traditional carpet weavers hard
- Holocaust survivors take on denial and hate in new digital campaign
subscribe via email
our twitter
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
To find out more, including how to control cookies, see here: Cookie Policy